Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc." Results 201 - 220 of 292
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 May 2020, 1:09 am by Schachtman
That was the tradition that stood in active need of reform when Daubert was decided in 1993. [read post]
24 Aug 2010, 11:34 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in which the Court instructed district courts to function as gatekeepers and permit only reliable and relevant expert testimony to be presented to the jury. [read post]
9 Oct 2018, 5:00 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), there are several factors that should be considered by a court when determining the admissibility of expert testimony. [read post]
3 Jan 2015, 3:47 pm by Robert Kreisman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) and granted BNSF’s motion for summary judgment. [read post]
4 Jul 2010, 4:16 pm
Merrell Dow Pharmaceuticals, Inc., 509 US 579 which, in federal courts, displaced the Frye general acceptance standard based upon the Federal Rules of Evidence. [read post]
19 Sep 2008, 8:13 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
5 Jun 2013, 5:29 am by Schachtman
Oct. 24, 1996) Merrell Dow Pharms., Inc. v. [read post]